For legalized marijuana, the coronavirus (COVID-19) pandemic has been the worst of times and the best of times.

Despite being deemed “ineligible” for much of the Coronavirus Aid, Relief and Economic Security Act (CARES Act) benefits, nearly derailed by commercial-contract-voiding force majeure provisions, and denied federal bankruptcy protection, COVID-19 has resulted in extraordinary marijuana-related business (MRB) advancements including online patient certification and ordering, curbside pickup, tripling the maximum purchasable amount and home delivery via caregivers.